Table 5.
Comparison between age groups.
| Patients < 2 years | p | Patients > 2 years | p | |||
|---|---|---|---|---|---|---|
| Control group (n = 42) | IA group (n = 23) | Control group (n = 37) | IA group (n = 83) | |||
| Basal characteristics | ||||||
| Age (months) | 8.50 (5-17) | 6 (4-9) | 0.081 | 60 (48-96) | 76 (53-120) | 0.159 |
| Males, n (%) | 26 (61.9%) | 13 (56.5%) | 0.678 | 22 (59.5%) | 46 (55.4%) | 0.683 |
| RACHS1 score | 2 (2-2) | 2 (2-3) | 0,750 | 2 (1-3) | 3 (2-3) | 0.052 |
| Extubation in OR, n (%) | 22 (54.4%) | 16 (69.6%) | 0.184 | 20 (54.1%) | 73 (88%) | 0.001 |
| Postoperative period | ||||||
| COMFORT scale | 19 (17.7-21.6) | 22 (19.5-23.7) | 0.058 | 19.3 (18.2-20.3) | 21.8 (20-23.5) | 0.001 |
| ANALGESIA scale | 1.5 (0.8-2.7) | 1.7 (1.2-2.2) | 0.983 | 1.75 (1-2.9) | 2 (1-2.7) | 0.971 |
| Days of iv fentanyl | 2 (1-3) | 1 (1-2) | 0.021 | 2 (1-3) | 0 (0-1,5) | 0.001 |
| Fentanyl dose (mcg/kg/h) | 1,5 (1-2) | 1.5 (0.87-2) | 0.398 | 1 (0.9-2) | 0.5 (0.5-1.25) | 0.254 |
| Days of iv midazolam | 1 (0-2) | 0 (0-0,5) | 0.304 | 0 (0-0.12) | 0 (0-0) | 0.792 |
| Midazolam dose (mcg/kg/min) | 2 (1-2) | 2 (1-2) | 0.319 | 3 (3-5) | 5 (3-8) | 0.040 |
| Days of iv propofol | 0 (0-2) | 0 (0-1) | 0.291 | 0 (0-0) | 0 (0-0) | 0.014 |
| Propofol dose (mg/kg/h) | 1.25 (1-2) | 1.75 (1-2) | 0.592 | 2.25 (1.25-2.87) | 1 (0.75-2) | 0.147 |
| MV duration (hours) | 19 (7.5-24) | 19 (6-48) | 0.598 | 8 (4-17) | 24 (2-30) | 0.073 |
| PICU LOS (days) | 4 (3-4) | 5 (3-6) | 0.039 | 2 (2-2) | 1 (1-2.5) | 0.040 |
IA: incisional analgesia; Iv: intravenous; OR: operating room; RACHS1 score: Risk Adjustment for Congenital Heart Surgery; MV: mechanical ventilation; PICU LOS: Pediatric Intensive Care Unit Length of Stay.